Company
Terumo
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
106
510(k), De Novo and PMA
Device trials
75
As lead sponsor, any status
Adverse event reports
3,825
Received Nov 1, 2025 to Nov 20, 2026
Recall records
668
One per recalled product
Terumo is on our public-company list (ticker 4543.T). Names searched as well: MicroVention. Naming a company here is not a recommendation of it or of any security.
Financing
Public company. Figures from its SEC financial statements.
Listed
4543.T
Listed outside the US
Public float
Unknown
Not reported in US filings
Revenue
Not reported
Net income
Not reported
R&D spending
Not reported
Cash
Not reported
Long-term debt
Not reported
Shares outstanding
Not reported
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Terumo.
Latest FDA decisions
The 8 newest of 106 since 2015.
- Progreat Lambda 2.1Fr510(k)
K261376 · Decided Nov 5, 2026 · 192 days after receipt
Device type: Catheter, Continuous Flush (KRA) · Cardiology
K254035 · Decided Sep 3, 2026 · 261 days after receipt
Device type: Aspiration Thrombectomy Catheter (QEZ) · Cardiology
- MISAGO(TM) RX Self-expanding Peripheral StentPMA supplement
P140002-S032 · Decided Jul 16, 2026 · 199 days after receipt · Panel Track
Device type: STENT, ILIAC (NIO) · Cardiology
103 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval StudyActive, not recruiting
NCT05409989 · 154 participants (planned) · Start Sep 20, 2022 · Primary completion Apr 2027
Device: FRED™ X™ · For: Intracranial Aneurysm
Sites: Hollywood, Florida; Orlando, Florida; Honolulu, Hawaii · 23 sites in all
NCT04839705 · 200 participants (planned) · Start Aug 24, 2022 · Primary completion May 8, 2027
Device: WEB · For: Wide Neck Bifurcation Intracranial Aneurysms
Sites: Hollywood, Florida; Orlando, Florida; Honolulu, Hawaii · 29 sites in all
NCT06215105 · 750 participants (planned) · Start Feb 19, 2024 · Primary completion Jan 2029
Device: Commercially available MicroVention Intracranial Aneurysm Treatment Devices · For: Cerebral Aneurysm; Intracranial Aneurysms
Sites: Walnut Creek, California; Englewood, Colorado; Hartford, Connecticut · 27 sites in all
72 more trials with a free account
Reports received
3,825
Received Nov 1, 2025 to Nov 20, 2026. Includes 8 of another or unstated type.
Malfunction reports
2,889
76% of reports
Injury reports
885
23% of reports
Death reports
43
1.1% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 147 | 116 | 4 | 0 |
| Jan 24 | 201 | 93 | 1 | 0 |
| Feb 24 | 196 | 98 | 1 | 0 |
| Mar 24 | 175 | 104 | 2 | 0 |
| Apr 24 | 194 | 104 | 8 | 0 |
| May 24 | 182 | 129 | 2 | 0 |
| Jun 24 | 159 | 110 | 3 | 0 |
| Jul 24 | 156 | 115 | 5 | 0 |
| Aug 24 | 149 | 149 | 1 | 0 |
| Sep 24 | 191 | 107 | 2 | 0 |
| Oct 24 | 170 | 127 | 4 | 1 |
| Nov 24 | 176 | 132 | 1 | 0 |
| Dec 24 | 225 | 123 | 1 | 0 |
| Jan 25 | 140 | 92 | 0 | 0 |
| Feb 25 | 140 | 145 | 3 | 0 |
| Mar 25 | 145 | 156 | 3 | 0 |
| Apr 25 | 184 | 106 | 3 | 1 |
| May 25 | 209 | 93 | 0 | 0 |
| Jun 25 | 187 | 79 | 3 | 0 |
| Jul 25 | 224 | 81 | 3 | 0 |
| Aug 25 | 227 | 93 | 8 | 1 |
| Sep 25 | 228 | 92 | 3 | 2 |
| Oct 25 | 244 | 100 | 8 | 0 |
| Nov 25 | 189 | 60 | 4 | 0 |
| Dec 25 | 198 | 84 | 2 | 0 |
| Jan 26 | 166 | 54 | 3 | 0 |
| Feb 26 | 164 | 85 | 2 | 0 |
| Mar 26 | 266 | 91 | 4 | 0 |
| Apr 26 | 296 | 85 | 5 | 0 |
| May 26 | 297 | 80 | 2 | 0 |
| Jun 26 | 303 | 78 | 6 | 0 |
| Jul 26 | 312 | 89 | 6 | 2 |
| Aug 26 | 246 | 63 | 5 | 5 |
| Sep 26 | 274 | 61 | 2 | 0 |
| Oct 26 | 178 | 55 | 2 | 1 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
7 more in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
- ANGIO-SEAL830
- TR BAND625
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2930-2026 · Started Jun 15, 2026 · Posted by FDA Aug 10, 2026
Reason given: Product was packaged with the 0.025 guidewire instead of the 0.021 guidewire.
Cause as FDA categorized it: Under Investigation by firm · Device type: Introducer, Catheter (DYB)
Z-2912-2026 · Started Apr 30, 2026 · Posted by FDA Aug 7, 2026
Reason given: Due to an increase rate of balloon pinhole defects.
Cause as FDA categorized it: Under Investigation by firm · Device type: Catheter, Percutaneous (DQY)
Z-2200-2026 · Started Apr 6, 2026 · Posted by FDA May 14, 2026
Reason given: Stent-assisted coiling device may due to commingling during manufacturing have dimensional nonconformance and/or incorrect device configuration. If device is oversized may lead to increased vessel wall stress, neointimal hyperplasia, vessel injury/rupture; if undersized may lead to incomplete expansion/malposition,...
Cause as FDA categorized it: Mixed-up of materials/components · Device type: Intracranial Coil-Assist Stent (QCA)
665 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.